Abstract
Over the past 40 years, sporadic Ebola virus disease (EVD) outbreaks have occurred mostly in the central African region. In March 2014, an outbreak of EVD was recognized in Guinea which would become the most significant outbreak of haemorrhagic fever in Africa to date. The outbreak started in Guinea and rapidly spread to Liberia and Sierra Leone, claiming thousands of lives. Many questions still remain regarding the ecology of Ebola viruses, but it is believed that contact with infected bushmeat is an important risk factor for initial spill over of the virus into the human population. At present, there is still no registered prophylaxis or curative biologicals against EVD.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Formenty P. Ebola virus disease. In: Ergönül O, Can F, Akova M, Madoff L (eds). Emerging infectious diseases, clinical case studies. Academic Press, 2014: 121–134. ISBN: 978-0-12-416975-3.
Kuhn JH, Boa Y, Bavari S, et al. Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol. 2013;158:301–11.
Negredo A, Palacios G, Vásquez-Morón S, et al. Discovery of an Ebolavirus-like filovirus in Europe. PLOS Path. 2011;7(10):e1002304.
Barrette RW, Xu L, Rowland JM, McIntosh MT. Current perspectives on the phylogeny of Filoviridae. Infect Genet Evol. 2011;11:1514–9.
World Health Organization. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ. 1978;56:271–93.
Johnson K, Webb P, Lange J, Murphy F. Isolation and partial characterization of a new virus causing haemorrhagic fever in Zaire. Lancet. 1977;1:569–71.
Heymann DL, Weisfield JS, Webb PA, et al. Ebola hemorrhagic fever: Tandala, Zaire, 1977–1978. J Infect Dis. 1980;142(3):372–6.
Khan AS, Tshioko FK, Heymann DL, et al. The re-emergence of Ebola haemorrhagic fever, Democratic Republic of Congo, 1995. J Infect Dis. 1999;179:S76–86.
Goerges A-J, Leroy EM, Renaut AA, et al. Ebola haemorrhagic fever outbreaks in Gabon, 1994–1997: epidemiological and health control issues. J Infect Dis. 1999;179 Suppl 1:S65–75.
World Health Organization. Outbreak(s) of Ebola haemorrhagic fever, Congo and Gabon, October 2001-July 2002. Weekly Epidemiological Report. 2003;78(26):223–5.
Formenty P, Leroy EM, Epelboin A, et al. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis. 2006;42:1521–6.
Leroy EM, Epelboin A, Mondonge V, et al. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector-borne and Zoonotic Diseases. 2009;9(6):723–8.
World Health Organization. End of Ebola outbreak in the Democratic Republic of Congo. http://www.who.int/csr/don/2009_02_17/en/. (Accessed 17 December 2014).
World Health Organization. WHO declares end of Ebola outbreak in the Democratic Republic of Congo. http://www.who.int/mediacentre/news/statements/2014/drc-ends-ebola/en/. Accessed: 17 December 2014.
The World Health Organization Ebola Response Team. Ebola Virus Disease in West Africa – the first 9 months of the epidemic and forward projections. NEJM. 2014;371(16):1481–95. A summary of the first nine months of the unprecedented outbreak of EVD in West Africa is summarized by key role players in the containment effort shedding light on the challenges and the vision forward for the containment of the outbreak.
Muyembe-Tamfum JJ, Mulangu S, Kayembe JM, Kemp A, Paweska JT. Ebola virus outbreaks in Africa: past and present. Onderstepoort J Vet Res. 2012;79(2):451. doi:10.1402/ojvr.v79i2.451.
World Health Organization. Ebola haemorrhagic fever in Sudan, 1976. Bull World Health Organ. 1978;56:247–70.
Baron RC, McCormick JB, Zubeir OA. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ. 1983;61(6):997–1003.
Okware SI, Omaswa FG, Zaramba S, et al. An outbreak of Ebola in Uganda. Trop Med Int Health. 2002;7(12):1068–75.
Towner JS, Sealy TK, Khristova ML, et al. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 2008;4:e1000212.
Wamala JF, Lukwago L, Malimbo M, et al. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007–2008. EID. 2010;16(7):1087–92.
Mbonye A, Wamala J, Kaboyo W, et al. Repeated outbreaks of viral haemorrhagic fevers in Uganda. Afr Health Sci. 2012;12(4):579–83.
MacNeil A, Farnon EC, Wamala J, et al. Proportion of deaths and clinical features in Bundibugyo Ebola virus infection. Uganda EID. 2010;16(12):1969–72.
Albarino CG, Shoemaker T, Khristova ML, et al. Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012. Virol. 2013;442(2):97–100.
Ebola virus infection in imported primates—Virginia, 1989. MMWR 1989; 38(48): 831–2, 837–8
Jahrling PB, Geisbert TW, Dalgard DW, et al. Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet. 1990;335(8688):502–5.
Update: filovirus infections among persons with occupational exposure to nonhuman primates. MMWR 1990; 39(16): 266–7; 237.
Miler RK, Baumgardner JY, Armstrong CN, et al. Update: filovirus infections in animal handlers. MMWR. 1990;39(13):221.
Morikawa S, Saijo M, Kurane I. Current knowledge on lower virulence of Reston Ebola virus (a review). Comp Immunol Microbiol Infect Dis. 2007;30:391–8.
Miranda ME, White ME, Dayrit MM, et al. Seroepidemiological study of filovirus related to Ebola in the Philippines. Lancet. 1991;337(3738):425–6.
Marsh GA, Haining J, Robinson R, et al. Ebola Reston virus infection of pigs: clinical significance and transmission potential. JID. 2011;204 Suppl 3:S804.
Formenty P, Hatz C, Le Guenno B, et al. Human infection due to Ebola virus, subtype Côte-d’Ivoire: clinical and biological presentation. J Infect Dis. 1999;179 Suppl 1:S48–53.
Pourrut X, Kumulungui B, Wittmann T, et al. The natural history of Ebola virus in Africa. Microbes Infect. 2005;7:1005–14.
Marzi A, Feldman H. Ebola virus vaccines: an overview of current approaches. Expert Rev Vaccines. 2014;13(4):521–31.
Richman DD, Cleveland PH, McCormick JB, et al. Antigenic analysis of strains of Ebola virus. Identification of two Ebola virus serotypes. J Infect Dis. 1983;147:268–71.
Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of Congo: clinical observations in 103 patients. J Infect Dis. 1999;179 Suppl 1:S1–7.
Guimard Y, Bwaka MA, Colebunders R, et al. Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of Congo, 1995. J Infect Dis. 1999;179(Suppl1):S268–73.
Shoemaker T, MacNeil A, Balinandi S, et al. Reemerging Sudan Ebola virus disease in Uganda, 2011. EID. 2002;18(9):1480–3.
Leroy EM, Gonzalez J-P, Baize S. Ebola and Marburg fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Clin Microbiol Infect. 2011;17:964–76.
World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. WHO, 2009. ISBN 978 92 4 156387 1
The World Health Organization. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. NEJM. 2014;371(16):1481–95.
Centers for Disease Control and Prevention. 2014 Ebola outbreak in West Africa—case counts. http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/case-counts.html (Accessed on 17 December 2014).
World Health Organization. WHO statement on the meeting of the International Health Regulations Emergency Committee regarding the 2014 Ebola outbreak in West Africa. http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/. (Accessed 17 December 2014).
Kucharski AJ, Edmunds WJ. Case fatality rate for Ebola virus disease in west Africa. Lancet. 2014;384:1260.
Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea—preliminary report. NEJM. 2014;371:1418–28. The first study to provide molecular typing data for currently circulating EBOV in Guinea to show that EBOV as causative agent of the outbreak. The paper also summarizes the index case and early evolvement of EVD in Guinea.
Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates virus origin and transmission during the 2014 outbreak. Science. 2014;345(6202):1369–72. Gire et al. provides the first account after extensive full genomic sequencing analysis of currently circulating EBOV in Sierra Leone and Guinea. The study estimates the introduction of EBOV in Guinea.
Dowall SD, Matthews DA, Garcia-Dorival I, et al. Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity. Genome Biol. 2014;15:540.
Chan M. Ebola virus disease in West Africa—no early end to the outbreak. NEJM. 2014;371:1183–5.
Fauci AS. Ebola—underscoring the global disparities in health care resources. NEJM. 2014;371:1084–6.
Meltzer MI, Atkins CY, Santibanez S, et al. Estimating the future number of cases in the Ebola epidemic—Liberia and Sierra Leone 2014–2015. MMWR. 2014;63(3):1–14.
Richards GA, Murphy S, Jobson R, et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiological aspects. Crit Care Med. 2000;28(1):240–4.
Shuaib F, Gunnala R, Musa EO, et al. Ebola virus disease outbreak—Nigeria, July-September 2014. MMWR. 2014;63(39):867–72.
Mirkovic K, Thwing J, Diack PA. Importation and containment of Ebola virus disease—Senegal, August—September 2014. MMWR. 2014;63(639):873–4.
Parra JM, Samerón OJ, Velasco M. The first case of Ebola virus disease acquired outside of Africa. NEJM. 2014;371:2439–40.
Chevalier MS, Chung W, Smith J, et al. Ebola virus disease cluster in the United States—Dallas County, Texas, 2014. MMWR. 2014;63:1–3.
Centers for Disease Control and Prevention. Cases of Ebola diagnosed in the United States. http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/united-states-imported-case.html (Accessed 18 December 2014)
World Health Organization. Mali confirms its first case of Ebola. http://www.who.int/mediacentre/news/ebola/24-october-2014/en/ (Accessed 18 December 2014)
World Health Organization. Mali confirms two new cases of Ebola virus disease. http://www.who.int/mediacentre/news/ebola/25-november-2014-mali/en/ (Accessed 18 December 2014).
Emond RT, Evans B, Bowen ET, et al. A case of Ebola virus infection. Br Med J. 1977;2(6086):541–4.
Borisevich IV, Markin VA, Firsova IV, et al. Hemorrhagic (Marburg, Ebola, Lassa and Bolivian) fevers: epidemiology, clinical pictures and treatment. Problems in Virology. 2006;51(5):8–16 [Russian].
Anonymous. Russian scientist dies after Ebola lab accident. Science 2004; 304 (5675): 1225.
Kortepeter MG, Martin JW, Rusnak JM, et al. Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit. EID. 2008;14:881–7.
Gűnther S, Feldmann H, Geisbert TW, et al. Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg. Germany JID. 2011;204 Suppl 3:S785.
World Health Organization. Viral haemorrhagic fever in imported monkeys. Weekly Epidemiological Record. 1992;67(24):183.
Carroll SA, Towner JS, Sealy TK, et al. Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences. J Virol. 2013;87(5):2608–16. Carroll and co-workers provide an important analysis of the relationship between Ebola and Marburg viruses, shedding light on the evolution of these viruses.
Groseth A, Feldmann H, Strong JE. The ecology of Ebola viruses. Trends Microbiol. 2007;15(9):408–16.
Rouquet P, Froment J-M, Bermejo M, et al. Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001–2003. EID 11(2): 283–290.
Leroy EM, Rouquet P, Formenty P, et al. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science. 2004;303(5656):387–90.
Whitfield J. Ape populations decimated by hunting and Ebola virus. Nature. 2003;422:551.
Leroy EM, Kumulungui B, Pourrut X, et al. Fruit bats as reservoirs of Ebola virus. Nature. 2007;438:575–6.
Pourrut X, Délicat A, Rollin PE, et al. Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. JID. 2007;196 Suppl 2:S176.
Hayman DTS, Yu M, Crameri G, et al. Ebola virus antibodies in fruit bats, Ghana, West Africa. EID. 2012;18(7):1207–09.
Pourrut X, Souris M, Towner JS, et al. Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect Dis. 2009;9:159.
Hayman DTS, Emmerich P, Yu M, et al. Long-term survival of an urban fruit bat seropositive for Ebola and Lagos bat viruses. PLoS One. 2010;5(8):e11978.
Biek R, Walsh PD, Leroy EM, et al. Recent common ancestry of Ebola Zaire virus found in a bat reservoir. PLOS Path. 2006;2(10):e90.
Marsh GA, Hainning J, Robinson R, et al. Ebola Reston infection in pigs: clinical significance and transmission potential. J Infect Dis. 2011;204 Suppl 3:S804–9.
Taniguchi A, Watanabe S, Masangkay JS, et al. Reston Ebolavirus antibodies in bats. Philippines EID. 2011;17(8):1559–60.
World Health Organization. WHO experts consultation on Ebola Reston pathogenicity in humans (WHO/HSE/EPR/2009.2). 2009; Geneva Switzerland.
Compliance with Ethics Guidelines
ᅟ
Conflict of Interest
All the authors have no conflict of interest to declare.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the author.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Tropical, Travel and Emerging Infections
Rights and permissions
About this article
Cite this article
Weyer, J., Grobbelaar, A. & Blumberg, L. Ebola Virus Disease: History, Epidemiology and Outbreaks. Curr Infect Dis Rep 17, 21 (2015). https://doi.org/10.1007/s11908-015-0480-y
Published:
DOI: https://doi.org/10.1007/s11908-015-0480-y